STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Reported by STAT News · all stories from statnews.com
Editorial digest
Digital health providers are actively offering GLP-1 medications for addiction without waiting for official FDA clearance. This report examines the growing trend of remote clinicians issuing unapproved indications for these popular metabolic drugs.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/5/2026
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah continues expanding health AI pilot programs for prescriptions and women's health.
- Trusted health newsroom10/8/2026
STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis
AI for breast cancer risk is now direct-to-consumer; regulatory concerns and AI-induced psychosis are also discussed.
- Trusted health newsroom10/15/2026
Opinion: MyChart said I could opt out of sharing my health data. Figuring out how was maddening
An opinion piece describes difficulties in opting out of health data sharing through MyChart.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom9/3/2026
STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized
FDA pilot program allows generative AI devices to reach patients pre-authorization.
- Trusted health newsroom9/1/2026
STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro
Stryker's system for surgery, using Apple Vision Pro, received FDA clearance.